Evidence map›Paper›PMID 41211111›Full record

ArticleAnnals of translational medicine2025

Polyglactin mesh in preventing recurrent pneumothorax in primary spontaneous pneumothorax: a retrospective efficacy study.

Jakraphan Yu, Sira Laohathai

Abstract read
In one paragraph

Article in Annals of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jakraphan YuDivision of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Sira LaohathaiDivision of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: At present, surgical bullectomy together with pleurodesis has the highest efficacy in terms of preventing the recurrence of primary spontaneous pneumothorax (PSP). There is still debate in the type of pleurodesis. In this study, we aim to investigate the efficacy of polyglactin mesh covering comparing to the standard surgical pleurodesis. Methods: This is a retrospective study collecting PSP patients who underwent bullectomy with pleurodesis between January 2016 and August 2023. The patients were divided into two groups as mesh and non-mesh group. Propensity score-matching analysis (1:1) was performed to balance the patient characteristics. The primary outcome was the pneumothorax recurrence after the index operation analyzed by Kaplan-Meier method. Operative and post-operative results were compared using Chi-squared test, Student's Results: There are 151 PSP patients during the study period, 84 and 67 of them were in mesh and non-mesh group respectively. After propensity matched, there were 49 patients in each group. From the Kaplan-Meier analysis with the longest follow-up time as 48 months, as the non-inferiority trial, there was no statistically significant between two groups (P=0.23). Importantly, the mesh group showed lower operative time for 15 minutes (P=0.01), lower blood loss for 10 mL (P<0.001), and shorter duration of chest tube for 1 day (P=0.002). Conclusions: In PSP patients undergoing lung bullectomy with pleurodesis, using of polyglactin mesh coverage the entire lung facilitates less operative time, less intra-operative blood loss and shorter both length of stay and chest tube duration. Polyglactin mesh should be considered as an alternative option for surgical pleurodesis.

Indexed as

hospitalizationLungpneumothoraxpolyglactinsurgical mesh

Identifiers

PMID41211111
PMCPMC12592006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.